Biological Assay for Activity and Molecular Mechanism of Retinoids in Cervical Tumor Cells
- 31 July 1997
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 66 (1) , 114-121
- https://doi.org/10.1006/gyno.1997.4736
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Epidermal Growth Factor Receptor, c-erbB-2 Proto-Oncogene and Estrogen Receptor Expression in Human Papillomavirus Lesions of the Uterine CervixInternational Journal of Gynecological Pathology, 1994
- 13-cis-Retinoic Acid Plus Interferon- 2a in Locally Advanced Squamous Cell Carcinoma of the CervixJNCI Journal of the National Cancer Institute, 1993
- Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.Journal of Clinical Pathology, 1993
- Epidermal Growth Factor Receptor Expression and the Presence of Human Papillomavirus in Cervical Squamous Intraepithelial LesionsInternational Journal of Gynecological Pathology, 1992
- 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the CervixJNCI Journal of the National Cancer Institute, 1992
- Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervixGynecologic Oncology, 1989
- Papillomaviruses in human cancersMolecular Carcinogenesis, 1988
- Clinical experience with topical tretinoin in the treatment of cervical dysplasiaJournal of the American Academy of Dermatology, 1986
- A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacyInvestigational New Drugs, 1986
- Retinoids and the prevention of cervical dysplasiasAmerican Journal of Obstetrics and Gynecology, 1981